Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations
Injection site reactions (ISRs; redness, swelling and pain) commonly occur within 1-2 days after vaccination. After administration of toxoid vaccines including diphtheria toxoid, a later onset of ISRs has also been observed. As the serotype capsular polysaccharides in the 13-valent pneumococcal conj...
Saved in:
Main Authors: | Christine Juergens (Author), James Trammel (Author), Yasuko Shoji (Author), Scott Patterson (Author), Wendy Watson (Author), Chris Webber (Author), William C. Gruber (Author), Daniel A. Scott (Author), Beate Schmoele-Thoma (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults
by: Beate Schmoele-Thoma, et al.
Published: (2019) -
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence
by: Erica Chilson, et al.
Published: (2020) -
Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial
by: Allison R. Thompson, et al.
Published: (2019) -
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial
by: Bhagirath B. Solanki, et al.
Published: (2017) -
Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age
by: Raul E. Isturiz, et al.
Published: (2018)